1.
Alkhalil E, Jarad B, Saleh T, Aldarwish W, Joujeh D. BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety. Prospect. Pharm. Sci. [Internet]. 2025 Feb. 5 [cited 2025 Oct. 3];23(1):31-46. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/292